The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Location of Persisting Mycobacteria in a Guinea Pig Model of Tuberculosis Revealed by R207910
Open accessAbstract
The lengthy chemotherapy of tuberculosis reflects the ability of a small subpopulation of Mycobacterium tuberculosis bacteria to persist in infected individuals. To date, the exact location of these persisting bacteria is not known. Lung lesions in guinea pigs infected with M. tuberculosis have striking similarities, such as necrosis, mineralization, and hypoxia, to natural infections in humans. Guinea pigs develop necrotic primary lesions after aerosol infection that differ in their morphology compared to secondary lesions resulting from hematogenous dissemination. In infected guinea pigs conventional therapy for tuberculosis during 6 weeks reduced the bacterial load by 1.7 logs in the lungs and, although this completely reversed lung inflammation associated with secondary lesions, the primary granulomas remained largely unaffected. Treatment of animals with the experimental drug R207910 (TMC207) for 6 weeks was highly effective with almost complete eradication of the bacteria throughout both the primary and the secondary lesions. Most importantly, the few remnants of acid-fast bacilli remaining after R207910 treatment were to be found extracellular, in a microenvironment of residual primary lesion necrosis with incomplete dystrophic calcification. This zone of the primary granuloma is hypoxic and is morphologically similar to what has been described for human lung lesions. These results show that this acellular rim may, therefore, be a primary location of persisting bacilli withstanding drug treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 4×
“pyl- -cyclodextrin solution as described before (2).”
BackgroundInfluentialSelf-citationWayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Tuberculosis: Pathogenesis, Protection and Control
(1996) · Nature Medicine · doi:10.1038/nm0296-244b · Cited by 977
M. tuberculosis persistence, latency, and drug tolerance
Gomez, J. E., & McKinney, J. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.08.003 · Cited by 533
Mechanisms of latency in Mycobacterium tuberculosis
Parrish, N. M., Dick, J. D., & Bishai, W. R. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01216-5 · Cited by 483
Tuberculosis — metabolism and respiration in the absence of growth
Boshoff, H. I. M., & Barry, C. E. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1065 · Cited by 448
Ojha, A., Anand, M., Bhatt, A., Kremer, L., Jacobs, W. R., & Hatfull, G. F. (2005) · Cell · doi:10.1016/j.cell.2005.09.012 · Cited by 422
New insights into the function of granulomas in human tuberculosis
Ulrichs, T., & Kaufmann, S. H. (2006) · The Journal of Pathology · doi:10.1002/path.1906 · Cited by 416
Tsai, M. C., Chakravarty, S., Zhu, G., Xu, J., Tanaka, K., Koch, C., Tufariello, J., Flynn, J., & Chan, J. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00612.x · Cited by 414
Hernández-Pando, R., Jeyanathan, M., Mengistu, G., Aguilar, D., Orozco, H., Harboe, M., Rook, G., & Bjune, G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03493-0 · Cited by 406
Is Adipose Tissue a Place for Mycobacterium tuberculosis Persistence?
Neyrolles, O., Hernández-Pando, R., Pietri-Rouxel, F., Fornès, P., Tailleux, L., Payán, J. A. B., Pivert, E., Bordat, Y., Aguilar, D., Prévost, M.-C., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000043 · Cited by 325
Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis
Nuermberger, E. L., Yoshimatsu, T., Tyagi, S., O'Brien, R. J., Vernon, A. N., Chaisson, R. E., Bishai, W. R., & Grosset, J. H. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200310-1380oc · Cited by 314
Lenaerts, A. J., Gruppo, V., Marietta, K. S., Johnson, C. M., Driscoll, D. K., Tompkins, N. M., Rose, J. D., Reynolds, R. C., & Orme, I. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2294-2301.2005 · Cited by 306
Self-citationArteel, G., Thurman, R., Yates, J., & Raleigh, J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.429 · Cited by 295
Cho, S. H., Warit, S., Wan, B., Hwang, C. H., Pauli, G. F., & Franzblau, S. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00055-06 · Cited by 292
Karakousis, P. C., Yoshimatsu, T., Lamichhane, G., Woolwine, S. C., Nuermberger, E. L., Grosset, J., & Bishai, W. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040646 · Cited by 237
Replication Dynamics of Mycobacterium tuberculosis in Chronically Infected Mice
Muñoz-Elías, E. J., Timm, J., Botha, T., Chan, W.-T., Gomez, J. E., & McKinney, J. D. (2005) · Infection and Immunity · doi:10.1128/iai.73.1.546-551.2005 · Cited by 226
Dannenberg, A. M., & Rook, G. A. W. (2014) · Tuberculosis · doi:10.1128/9781555818357.ch27 · Cited by 195
Oxygen status of lung granulomas in Mycobacterium tuberculosis‐infected mice
Aly, S., Wagner, K., Keller, C., Malm, S., Malzan, A., Brandau, S., Bange, F., & Ehlers, S. (2006) · The Journal of Pathology · doi:10.1002/path.2055 · Cited by 185
Self-citationArteel, G. E., Thurman, R. G., & Raleigh, J. A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2530743.x · Cited by 176
Synergistic Activity of R207910 Combined with Pyrazinamide against Murine Tuberculosis
Ibrahim, M., Andries, K., Lounis, N., Chauffour, A., Truffot-Pernot, C., Jarlier, V., & Veziris, N. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00898-06 · Cited by 175
Self-citationBrandt, L., Skeiky, Y. A. W., Alderson, M. R., Lobet, Y., Dalemans, W., Turner, O. C., Basaraba, R. J., Izzo, A. A., Lasco, T. M., Chapman, P. L., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6622-6632.2004 · Cited by 174
Self-citationCharacterization of biofilm formation by clinical isolates of Mycobacterium avium
Carter, G., Wu, M., Drummond, D. C., & Bermudez, L. E. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05224-0 · Cited by 169
Suarez, S., O'Hara, P., Kazantseva, M., Newcomer, C. E., Hopfer, R., McMurray, D. N., & Hickey, A. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1013094112861 · Cited by 159
Lamichhane, G., Tyagi, S. K., & Bishai, W. R. (2005) · Infection and Immunity · doi:10.1128/iai.73.4.2533-2540.2005 · Cited by 158
Lounis, N., Véziris, N., Chauffour, A., Truffot-Pernot, C., Andries, K., & Jarlier, V. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-06 · Cited by 143
Self-citationDisease model: pulmonary tuberculosis
McMurray, D. N. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(00)01901-8 · Cited by 139
Yamazaki, Y., Danelishvili, L., Wu, M., Hidaka, E., Katsuyama, T., Stang, B. V., Petrofsky, M., Bildfell, R. J., & Bermudez, L. E. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00667.x · Cited by 132
Ulrichs, T., Lefmann, M., Reich, M., Morawietz, L., Roth, A., Brinkmann, V., Kosmiadi, G., Seiler, P., Aichele, P., Hahn, H., et al. (2005) · Journal of Pathology · doi:10.1002/path.1728 · Cited by 110
Lessons From a Proficiency Testing Event for Acid-Fast Microscopy
Somoskövi, Á., Hotaling, J. E., Fitzgerald, M., et al. (2001) · CHEST Journal · doi:10.1378/chest.120.1.250 · Cited by 109
Pathogenesis of Experimental Tuberculosis in Animal Models
McMurray, D. N., Collins, F. M., Dannenberg, A. M., & Smith, D. W. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80166-2_7 · Cited by 106
Mycobacterium aviumGenes Associated with the Ability To Form a Biofilm
Yamazaki, Y., Danelishvili, L., Wu, M., MacNab, M., & Bermudez, L. E. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.1.819-825.2006 · Cited by 95
McMurray, D. N. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00079-3 · Cited by 80
Mycobacterial Biofilms: A Greasy Way to Hold It Together
Zambrano, M. M., & Kolter, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.011 · Cited by 75
Lymphadenitis as a major element of disease in the guinea pig model of tuberculosis
Basaraba, R. J., Dailey, D. D., McFarland, C. T., Shanley, C. A., Smith, E. E., McMurray, D. N., & Orme, I. M. (2006) · Tuberculosis · doi:10.1016/j.tube.2005.11.003 · Cited by 56
Self-citationJohnson, C. M., Pandey, R., Sharma, S., Khuller, G. K., Basaraba, R. J., Orme, I. M., & Lenaerts, A. J. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4335-4338.2005 · Cited by 52
Self-citationInvolvement of Mycobacterium smegmatis undecaprenyl phosphokinase in biofilm and smegma formation
Röse, L., Kaufmann, S. H. E., & Daugelat, S. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.05.011 · Cited by 49
Gruppo, V., Johnson, C. M., Marietta, K. S., Scherman, H., Zink, E. E., Crick, D. C., Adams, L. B., Orme, I. M., & Lenaerts, A. J. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1245-1250.2006 · Cited by 45
Self-citationGranulomatous Infections and Inflammations: Cellular and Molecular Mechanisms
Boros, D. L. (2003) · Cited by 38
Rekindling old controversy on elusive lair of latent tuberculosis
Bishai, W. R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03485-1 · Cited by 28
Cited by
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
Via, L. E., Lin, P. L., Ray, S. M., Carrillo, J., Allen, S. S., Eum, S. Y., Taylor, K., Klein, E., Manjunatha, U., Gonzales, J., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01515-07 · Cited by 664
Ojha, A. K., Baughn, A. D., Sambandan, D., Hsu, T., Trivelli, X., Guerardel, Y., Alahari, A., Kremer, L., Jacobs, W. R., & Hatfull, G. F. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06274.x · Cited by 545
The association between sterilizing activity and drug distribution into tuberculosis lesions
Prideaux, B., Via, L. E., Zimmerman, M. D., Eum, S., Sarathy, J., O'Brien, P., Chen, C., Kaya, F., Weiner, D. M., Chen, P.-Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3937 · Cited by 461
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
Alsultan, A., & Peloquin, C. A. (2014) · Drugs · doi:10.1007/s40265-014-0222-8 · Cited by 444
Metadata
- Authors
- Lenaerts, A. J., Hoff, D., Aly, S., Ehlers, S., Andries, K., Cantarero, L., Orme, I. M., & Basaraba, R. J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-09
- Volume
- 51
- Issue
- 9
- Pages
- 3338-3345
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2139451383
- Cited by
- 257
- References
- 41
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.